Cargando…

Experimental Chemotherapy for Chagas Disease: A Morphological, Biochemical, and Proteomic Overview of Potential Trypanosoma cruzi Targets of Amidines Derivatives and Naphthoquinones

Chagas disease (CD), caused by Trypanosoma cruzi, affects approximately eight million individuals in Latin America and is emerging in nonendemic areas due to the globalisation of immigration and nonvectorial transmission routes. Although CD represents an important public health problem, resulting in...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Castro, Solange L., Batista, Denise G. J., Batista, Marcos M., Batista, Wanderson, Daliry, Anissa, de Souza, Elen M., Menna-Barreto, Rubem F. S., Oliveira, Gabriel M., Salomão, Kelly, Silva, Cristiane F., Silva, Patricia B., Soeiro, Maria de Nazaré C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE-Hindawi Access to Research 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195292/ https://www.ncbi.nlm.nih.gov/pubmed/22091400 http://dx.doi.org/10.4061/2011/306928

Ejemplares similares

Trypanosoma cruzi mitochondrial swelling and membrane potential collapse as primary evidence of the mode of action of naphthoquinone analogues
por: Salomão, Kelly, et al.
Publicado: (2013)

Antiparasitic Activity of Plumbago auriculata Extracts and Its Naphthoquinone Plumbagin against Trypanosoma cruzi
por: Peres, Raiza Brandão, et al.
Publicado: (2023)

Nucleoside triphosphate diphosphohydrolase1 (TcNTPDase-1) gene expression is increased due to heat shock and in infective forms of Trypanosoma cruzi
por: Silva-Gomes, Natália Lins, et al.
Publicado: (2014)

In Vitro and In Vivo Investigation of the Efficacy of Arylimidamide DB1831 and Its Mesylated Salt Form - DB1965 - against Trypanosoma cruzi Infection
por: da Silva, Cristiane França, et al.
Publicado: (2012)

Overexpression of TcNTPDase-1 Gene Increases Infectivity in Mice Infected with Trypanosoma cruzi
por: da Silva-Gomes, Natália Lins, et al.
Publicado: (2022)

Screening of Potential anti-Trypanosoma cruzi Candidates: In Vitro and In Vivo Studies
por: Soeiro, Maria de Nazaré C, et al.
Publicado: (2011)

The Impact of the CTHRSSVVC Peptide Upon Experimental Models of Trypanosoma cruzi Infection
por: Leite, Gabriela Rodrigues, et al.
Publicado: (2022)

Combined Treatment of Heterocyclic Analogues and Benznidazole upon Trypanosoma cruzi In Vivo
por: Batista, Denise da Gama Jaén, et al.
Publicado: (2011)

Efficacy of sertraline against Trypanosoma cruzi: an in vitro and in silico study
por: Ferreira, Daiane Dias, et al.
Publicado: (2018)

Benznidazole and amiodarone combined treatment attenuates cytoskeletal damage in Trypanosoma cruzi-infected cardiac cells
por: Barbosa, Juliana Magalhães Chaves, et al.
Publicado: (2022)

In vitro and in silico analysis of imatinib analogues as anti-Trypanosoma cruzi drug candidates
por: Nesic de Freitas, Luca S. F., et al.
Publicado: (2023)

Impact of autologous whole blood administration upon experimental mouse models of acute Trypanosoma cruzi infection
por: Philot Pavão, Beatriz, et al.
Publicado: (2018)

In Chagas disease, transforming growth factor beta neutralization reduces Trypanosoma cruzi infection and improves cardiac performance
por: Ferreira, Roberto Rodrigues, et al.
Publicado: (2022)

Phenotypic evaluation and in silico ADMET properties of novel arylimidamides in acute mouse models of Trypanosoma cruzi infection
por: da Silva, Cristiane França, et al.
Publicado: (2017)

Experimental Combination Therapy with Amiodarone and Low-Dose Benznidazole in a Mouse Model of Trypanosoma cruzi Acute Infection
por: Barbosa, Juliana Magalhães Chaves, et al.
Publicado: (2022)

Antiparasitic and anti-inflammatory activities of ß-lapachone-derived naphthoimidazoles in experimental acute Trypanosoma cruzi infection
por: Cascabulho, Cynthia M, et al.
Publicado: (2020)

Phenotypic Evaluation of Nucleoside Analogues against Trypanosoma cruzi Infection: In Vitro and In Vivo Approaches
por: Fiuza, Ludmila F. de A., et al.
Publicado: (2022)

Arylimidamides Have Potential for Chemoprophylaxis against Blood-Transmitted Chagas Disease
por: Timm, Bruno Lisboa, et al.
Publicado: (2023)

Norfloxacin and N-Donor Mixed-Ligand Copper(II) Complexes: Synthesis, Albumin Interaction, and Anti-Trypanosoma cruzi Activity
por: Martins, Darliane A., et al.
Publicado: (2016)

Brazilian Green Propolis: Effects In Vitro and In Vivo on Trypanosoma cruzi
por: Salomão, Kelly, et al.
Publicado: (2011)

In Vitro Phenotypic Activity and In Silico Analysis of Natural Products from Brazilian Biodiversity on Trypanosoma cruzi
por: Peres, Raiza B., et al.
Publicado: (2021)

Peeking into the mysterious world of Trypanosoma cruzi and Chagas disease
por: Macedo, Andréa M, et al.
Publicado: (2022)

Electrocardiographic Findings in Acutely and Chronically T. cruzi-infected Mice Treated by a Phenyl-Substituted Analogue of Furamidine DB569
por: de Souza, Elen M., et al.
Publicado: (2007)

Expression and cellular localisation of Trypanosoma cruzi calpains
por: Ennes-Vidal, Vítor, et al.
Publicado: (2020)

Clathrin expression in Trypanosoma cruzi
por: Kalb, Ligia Cristina, et al.
Publicado: (2014)

Characterising ISWI chromatin remodeler in Trypanosoma cruzi
por: Díaz-Olmos, Yirys, et al.
Publicado: (2020)

Participation of Central Muscarinic Receptors on the Nervous Form of Chagas Disease in Mice Infected via Intracerebroventricular with Colombian Trypanosoma cruzi Strain
por: de Assis, Gabriela Maira Pereira, et al.
Publicado: (2021)

Extracellular Vesicles: Potential Role in Remote Signaling and Inflammation in Trypanosoma cruzi-Triggered Disease
por: Dantas-Pereira, Luíza, et al.
Publicado: (2021)

Meiotic sex in Chagas disease parasite Trypanosoma cruzi
por: Schwabl, Philipp, et al.
Publicado: (2019)

Trypanosoma cruzi and Chagas disease: diversity, progress and challenges
por: Miles, Michael A
Publicado: (2022)

New Amino Naphthoquinone Derivatives as Anti-Trypanosoma cruzi Agents Targeting Trypanothione Reductase
por: Espinosa-Bustos, Christian, et al.
Publicado: (2022)

A systematic review of the diagnostic aspects and use of Trypanosoma rangeli as an immunogen for Trypanosoma cruzi infection
por: Bayão, Taciana de Souza, et al.
Publicado: (2020)

Trypanosoma cruzi loop-mediated isothermal amplification (Trypanosoma cruzi Loopamp) kit for detection of congenital, acute and Chagas disease reactivation
por: Besuschio, Susana A., et al.
Publicado: (2020)

Validation of the NAT Chagas IVD Kit for the Detection and Quantification of Trypanosoma cruzi in Blood Samples of Patients with Chagas Disease
por: Moreira, Otacilio C., et al.
Publicado: (2023)

Performance of Chimeric Trypanosoma cruzi Antigens in Serological Screening for Chagas Disease in Blood Banks
por: dos Santos, Emily Ferreira, et al.
Publicado: (2022)

Benznidazole/Itraconazole Combination Treatment Enhances Anti-Trypanosoma cruzi Activity in Experimental Chagas Disease
por: Assíria Fontes Martins, Tassiane, et al.
Publicado: (2015)

Trypanosoma cruzi strain TcI is associated with chronic Chagas disease in the Brazilian Amazon
por: Santana, Rosa Amélia Gonçalves, et al.
Publicado: (2014)

Unraveling Chagas disease transmission through the oral route: Gateways to Trypanosoma cruzi infection and target tissues
por: Silva-dos-Santos, Danielle, et al.
Publicado: (2017)

Perspectives for a new drug candidate for Chagas disease therapy
por: Soeiro, Maria de Nazaré Correia
Publicado: (2022)

Combination With Tomatidine Improves the Potency of Posaconazole Against Trypanosoma cruzi
por: Rocha-Hasler, Marianne, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p89ummrgk1hqph2btp1t1kb19m